2010
Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users
Paintsil E, He H, Peters C, Lindenbach BD, Heimer R. Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users. The Journal Of Infectious Diseases 2010, 202: 984-990. PMID: 20726768, PMCID: PMC2932767, DOI: 10.1086/656212.Peer-Reviewed Original ResearchConceptsHepatitis C virusInjection drug usersDrug usersC virusHigh prevalenceInsulin syringesViable virusTuberculin syringesHCV infectivityResidual volumeReporter virusDay 1Prevention strategiesDay 7Microculture assayDay 63VirusLuciferase activitySyringesDegrees CPrevalenceVirus survivalSurvivalVirus decay ratesDays
2009
Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection
Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection. Addiction 2009, 104: 1881-1890. PMID: 19712125, PMCID: PMC2763027, DOI: 10.1111/j.1360-0443.2009.02687.x.Peer-Reviewed Original ResearchConceptsInjection drug usersHepatitis C virusRespondent-driven samplingPrevalent infectionMajority of IDUsHepatitis C virus infectionSustained virological responseC virus infectionRespondent-driven sampleAssociation of genotypesIDU communityVirological responseHCV infectionAntiviral therapyC virusGenotype 3aDrug injectionVirus infectionDrug injectorsBlood samplesHCV sequencesDrug usersEndemic infectionInfectionMolecular epidemiology